A Phase II Study Of Irinotecan (Camptosar) And Paclitaxel (Taxol) In Patients With Adenocarcinoma Of The Upper Gastrointestinal Tract
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2012
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 09 Mar 2010 Actual number of patients (51) added as reported by ClinicalTrials.gov record.
- 09 Mar 2010 Actual end date (1 Aug 2005) added as reported by ClinicalTrials.gov record.
- 09 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.